EGFR and non-small cell lung carcinoma: Cai reported that high CEAIn level (>5 ng/mL) was associated with EGFR mutation status and correlated with poor OS in stage I-IIIA NSCLC patients, who were not divided into EGFR-wild and mutant groups32.